Abstract
Hetarylfuroxans (4-(2-methylpyridin-5-yloxy)-3-phenylfuroxan (1), bis(1,2,4-oxadiazol- 3-yl)furoxan (2), and 4-amino-3-(indenotriazin-3-yl)furoxan (3)) exhibit in vitro cytotoxic activity against chronic myeloid leukemia K562 cells. All studied furoxans induce apoptosis in K562 cells. The experiments with activation of caspases-3 and -7 showed that furoxan 3 possessed the highest apoptosis-inducing capacity. The studied hetarylfuroxans were found to be the promising drug candidates for the treatment of chronic myeloid leukemia K562.
Similar content being viewed by others
References
D. J. L. Joske, Med. J. Aust., 2008, 189, 277.
C.G. Geary, Br. J. Haematol., 2000, 110, 2.
B. J. Druker, C. L. Sawyers, H. Kantarjian, D. J. Resta, S. F. Reese, J. M. Ford, R. Capdeville, M. Talpaz, N. Engl. J. Med., 2001, 344, 1038.
E. Jabbour, H. Kantarjian, Am. J. Hematol., 2016, 91, 252.
B. H. Moreno, E. C. Garralda, R. Hitt, Clin. Transl. Oncol., 2010, 12, 468.
L. D. Azevedo, M. M. Bastos, F. C. Vasconcelos, L. V. B. Hoelz, F. P. S. Junior, R. F. Dantas, A. C. M. de Almeida, A. P. de Oliveira, L. C. Gomes, R. C. Maia, N. Boechat, Med. Chem. Res., 2017, 26, 2929.
G. Rosti, F. Castagnetti, G. Gugliotta, F. Palandri, M. Baccarani, Cancer Treat. Rev., 2012, 38, 241.
R. Cheng, L. A. Ridnour, S. A. Glynn, C. H. Switzer, W. Flores-Santana, P. Hussain, D. D. Thomas, S. Ambs, C. C. Harris, D. A. Wink, in Nitric Oxide and Cancer. Prognosis, Prevention and Therapy, Ed. B. Bonavida, Springer, New York, 2010, Chapter 1, p. 3.
M. R. Miller, I. L. Megson, Br. J. Pharmacol., 2007, 151, 305.
N. N. Makhova, L. L. Fershtat, Tetrahedron Lett., 2018, 59, 2317.
A. Gasco, K. Schoenafinger, in Nitric Oxide Donors: For Pharmaceutical and Biological Applications, Eds P. G. Wang, T. B. Cai, N. Taniguchi, Wiley-VCH, Weinheim, 2005, p. 131.
L. L. Fershtat, N. N. Makhova, Russ. Chem. Rev., 2016, 85, 1097.
L. L. Fershtat, N. N. Makhova, ChemMedChem, 2017, 12, 622.
T. Schiefer, L. VandeVrede, M. Fa, O. Arancio, G. R. J. Thatcher, J. Med. Chem., 2012, 55, 3076.
J. L. Dos Santos, C. Lanaro, R. C. Chelucci, S. Gambero, P. L. Bosquesi, J. S. Reis, L. M. Lima, H. Cerecetto, M. Gonzalez, F. F. Costa, M. C. Chung, J. Med. Chem., 2012, 55, 7583.
N. E. Ustyuzhanina, L. L. Fershtat, M. L. Gening, N. E. Nifantiev, N. N. Makhova, Mendeleev Commun., 2016, 26, 513.
N. E. Ustyuzhanina, L. L. Fershtat, M. L. Gening, N. E. Nifantiev, N. N. Makhova, Mendeleev Commun., 2018, 28, 49.
S. G. Zlotin, A. M. Churakov, I. L. Dalinger, O. A. Luk´yanov, N. N. Makhova, A. Yu. Sukhorukov, V. A. Tartakovsky, Mendeleev Commun., 2017, 27, 535.
A. S. Kulikov, M. A. Epishina, A. I. Churakov, L. V. Anikina, L. L. Fershtat, N. N. Makhova, Mendeleev Commun., 2018, 28, 623.
A. A. Larin, L. L. Fershtat, N. E. Ustyuzhanina, M. L. Gening, N. E. Nifantiev, N. N. Makhova, Mendeleev Commun., 2018, 28, 595.
H. Cerecetto, W. Porcal, Mini-Rev. Med. Chem., 2005, 5, 57.
A. S. Kulikov, A. A. Larin, L. L. Fershtat, L. V. Anikina, S. A. Pukhov, S. G. Klochkov, M. I. Struchkova, A. A. Romanova, I. V. Ananyev, N. N. Makhova, Arkivoc, 2017, Part III, 250.
L. L. Fershtat, M. A. Epishina, A. S. Kulikov, M. I. Struchkova, N. N. Makhova, Chem. Heterocycl. Compd., 2015, 51, 176.
L. L. Fershtat, I. V. Ananyev, N. N. Makhova, RSC Adv., 2015, 5, 47248.
L. L. Fershtat, A. A. Larin, M. A. Epishina, I. V. Ovchinnikov, A. S. Kulikov, I. V. Ananyev, N. N. Makhova, RSC Adv., 2016, 6, 31526.
A. Ashkenazi, V. M. Dixit, Science, 1998, 281, 1305.
H. Steller, Science, 1995, 267, 1445.
D. M. Pereira, G. Correia-da-Silva, P. Valentão, N. Teixeira, P. B. Andrade, Mar. Drugs, 2014, 12, 54.
E. A. Slee, C. Adrain, S. J. Martin, Cell Death Diff., 1999, 6, 1067.
N. A. Thornberry, T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P. A. Nordstrom, S. Roy, J. P. Vaillancourt, K. T. Chapman, D. W. Nicholson, J. Biol. Chem., 1997, 272, 17907.
J. O´Brien, I. Wilson, T. Orton, F. Pognan, Eur. J. Biochem., 2000, 267, 5421.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 1, pp. 0158–0162, January, 2019.
Rights and permissions
About this article
Cite this article
Pukhov, S.A., Anikina, L.A., Larin, A.A. et al. Hetarylfuroxans: cytotoxic effect and induction of apoptosis in chronic myeloid leukemia K562 cells. Russ Chem Bull 68, 158–162 (2019). https://doi.org/10.1007/s11172-019-2431-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-019-2431-5